ORIGINAL RESEARCH Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.

  2011cited by this paper
• Multivariate Analysis of 1H-NMR Spectra of Genetically Characterized Extra Virgin Olive Oils and Growth Soil Correlations

  2011cited by this paper
• Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

  2011cited by this paper
• An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging

  2010cited by this paper
• Glioblastomas with Oligodendroglial Component – Common Origin of the Different Histological Parts and Genetic Subclassification

  2010cited by this paper
• Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging.

  2010cited by this paper
• Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

  2010cited by this paper
• Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults.

  2010cited by this paper
• Genetic alterations and signaling pathways in the evolution of gliomas

  2009cited by this paper
• FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme.

  2009cited by this paper
• Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

  2009cited by this paper
• Genetic signature of adult gliomas and correlation with MRI features

  2009cited by this paper
• Antiangiogenic therapies for high-grade glioma

  2009cited by this paper
• IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors

  2009cited by this paper
• Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

  2009cited by this paper
• Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone

  2009cited by this paper
• Mutant metabolic enzymes are at the origin of gliomas.

  2009cited by this paper
• Diagnostic and prognostic markers in gliomas

  2009cited by this paper
• Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis

  2009cited by this paper
• Monoclonal antibody specific for IDH1 R132H mutation

  2009cited by this paper
• IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.

  2009cited by this paper
• Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis.

  2008cited by this paper
• Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

  2008cited by this paper
• Analysis of the IDH1 codon 132 mutation in brain tumors

  2008cited by this paper
• Relationship between Survival and Edema in Malignant Gliomas: Role of Vascular Endothelial Growth Factor and Neuronal Pentraxin 2

  2007cited by this paper
• Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype.

  2007cited by this paper
• Microarray Analysis of MRI-defined Tissue Samples in Glioblastoma Reveals Differences in Regional Expression of Therapeutic Targets

  2006cited by this paper
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

  2006cited by this paper
• Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

  2004cited by this paper
• A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

  2001cited by this paper
• MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

  1999cited by this paper
• Germline p53 gene mutations in subsets of glioma patients.

  1994cited by this paper
• Bmc Medical Genomics Gene Expression Analysis of Glioblastomas Identifies the Major Molecular Basis for the Prognostic Benefit of Younger Age

  year unknowncited by this paper

• Importance of Age and Noncontrast-Enhancing Tumor as Biomarkers for Isocitrate Dehydrogenase–Mutant Glioblastoma: A Multicenter Study

  2023cites this paper
• Diffusion Weighted Imaging in Neuro-Oncology: Diagnosis, Post-Treatment Changes, and Advanced Sequences—An Updated Review

  2023cites this paper
• Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor

  2023cites this paper
• Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium

  2023cites this paper
• Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study

  2023influential citation
• Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI

  2023cites this paper
• From Theory to Practice: Implementing the WHO 2021 Classification of Adult Diffuse Gliomas in Neuropathology Diagnosis

  2023cites this paper
• Mutant IDH in Gliomas: Role in Cancer and Treatment Options

  2023cites this paper
• Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis

  2022cites this paper
• MRI features predict tumor grade in isocitrate dehydrogenase (IDH)–mutant astrocytoma and oligodendroglioma

  2022cites this paper
• Basic premises: searching for new targets and strategies in diffuse gliomas

  2022cites this paper
• The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study

  2022cites this paper
• Diffuse glioma, not otherwise specified: imaging-based risk stratification achieves histomolecular-level prognostication

  2022cites this paper
• The Extent of Resection in Gliomas-Evidence-Based Recommendations on Methodological Aspects of Research Design.

  2022cites this paper
• Classification and Diagnosis of Adult Glioma: A Scoping Review

  2022cites this paper
• A radiomics model based on DCE-MRI and DWI may improve the prediction of estimating IDH1 mutation and angiogenesis in gliomas.

  2022cites this paper
• Multiparametric Magnetic Resonance Imaging Correlates of Isocitrate Dehydrogenase Mutation in WHO high-Grade Astrocytomas

  2022cites this paper
• Standard deviations of MR signal intensities show a consistent trend during imaging follow-ups for glioblastoma patients when corrected for non-biological heterogeneity due to hardware and software variation.

  2022cites this paper
• Radiogenomic Predictors of Recurrence in Glioblastoma—A Systematic Review

  2022cites this paper
• Immune landscape-based machine-learning–assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma

  2022cites this paper
• Factors Involved in Preoperative Edema in High-Grade Gliomas

  2022influential citation
• Identifying overall survival in 98 glioblastomas using VASARI features at 3T.

  2022cites this paper
• Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system

  2021cites this paper
• FACTORS AFFECTING OUTCOME IN THE TREATMENT OF GLIOBLASTOMA

  2021cites this paper
• Is It Worth Considering Multicentric High-Grade Glioma a Surgical Disease? Analysis of Our Clinical Experience and Literature Review

  2021cites this paper
• Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant

  2021cites this paper
• Advanced Imaging and Computational Techniques for the Diagnostic and Prognostic Assessment of Malignant Gliomas

  2021cites this paper
• Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light

  2021cites this paper
• The Value of Immunohistochemical Methods and Preoperative Magnetic Resonance Imaging Findings in Diagnosis of IDH1 Mutant Glioblastomas.

  2021cites this paper
• MRI Imaging Characteristics of Glioblastoma with Concurrent Gain of Chromosomes 19 and 20

  2021cites this paper
• Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis

  2021cites this paper
• The Prognostic Role of Peritumoral Edema in Patients with Newly Diagnosed Glioblastoma: A Retrospective Analysis.

  2021cites this paper
• Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort study

  2021cites this paper
• Imaging Findings of New Entities and Patterns in Brain Tumor: Isocitrate Dehydrogenase Mutant, Isocitrate Dehydrogenase Wild-Type, Codeletion, and MGMT Methylation.

  2021cites this paper
• Radiogenomics of Gliomas.

  2021cites this paper
• Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.

  2021cites this paper
• Fluid attenuation in non‐contrast‐enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma

  2021cites this paper
• The Nomogram of MRI‐based Radiomics with Complementary Visual Features by Machine Learning Improves Stratification of Glioblastoma Patients: A Multicenter Study

  2021cites this paper
• Conventional and advanced imaging throughout the cycle of care of gliomas

  2021cites this paper
• Prognostic relevance of CSF and peri-tumoral edema volumes in glioblastoma.

  2021cites this paper
• Machine Learning in Clinical Neuroimaging and Radiogenomics in Neuro-oncology: Third International Workshop, MLCN 2020, and Second International Workshop, RNO-AI 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4–8, 2020, Proceedings

  2020cites this paper
• 'Real world' use of a highly reliable imaging sign: 'T2-FLAIR mismatch' for identification of IDH mutant astrocytomas.

  2020cites this paper
• Automated MRI based pipeline for segmentation and prediction of grade, IDH mutation and 1p19q co-deletion in glioma

  2020cites this paper
• Machine Learning Methods for Image Analysis in Medical Applications, from Alzheimer's Disease, Brain Tumors, to Assisted Living

  2020cites this paper
• A single-centre observational study of 124 surgically managed glioma patients: molecular subtyping and its correlation with clinico-radiological profile

  2020cites this paper
• MRI Morphometry in Brain Tumors: Challenges and Opportunities in Expert, Radiomic, and Deep-Learning-Based Analyses

  2020cites this paper
• Radiogenomics of Glioblastoma: Identification of Radiomics associated with Molecular Subtypes

  2020cites this paper
• Updates on Deep Learning and Glioma: Use of Convolutional Neural Networks to Image Glioma Heterogeneity.

  2020cites this paper
• WHO 2016 subtyping and automated segmentation of glioma using multi-task deep learning

  2020cites this paper
• Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models

  2020cites this paper
• A radiomics-clinical nomogram for preoperative prediction of IDH1 mutation in primary glioblastoma multiforme.

  2020cites this paper
• Neuro-Oncology and Radiogenomics: Time to Integrate?

  2020cites this paper
• Main genetic differences in high-grade gliomas may present different MR imaging and MR spectroscopy correlates

  2020cites this paper
• Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review

  2020influential citation
• Asymmetric tumor‐related alterations of network‐specific intrinsic functional connectivity in glioma patients

  2020cites this paper
• No association between isocitrate dehydrogenase 1 mutation and increased survival of glioblastoma: A meta-analysis

  2020cites this paper
• Structural plasticity of the bilateral hippocampus in glioma patients

  2020cites this paper
• Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries: 5th International Workshop, BrainLes 2019, Held in Conjunction with MICCAI 2019, Shenzhen, China, October 17, 2019, Revised Selected Papers, Part I

  2020cites this paper
• Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

  2020cites this paper
• Radiological differences between subtypes of WHO 2016 grade II–III gliomas: a systematic review and meta-analysis

  2020cites this paper
• Precision of preoperative diagnosis in patients with brain tumor – A prospective study based on “top three list” of differential diagnosis for 1061 patients

  2020cites this paper
• Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype

  2020cites this paper
• Lipid Fraction Derived From MRI In- and Opposed-Phase Sequence as a Novel Biomarker for Predicting Survival Outcome of Glioma.

  2020cites this paper
• A quantitative model based on clinically relevant MRI features differentiates lower grade gliomas and glioblastoma

  2020cites this paper
• A view of the epidemiologic landscape: how population-based studies can lend novel insights regarding the pathophysiology of glioblastoma.

  2020cites this paper
• Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.

  2020cites this paper
• Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review

  2020cites this paper
• Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification.

  2020cites this paper
• Adult Glioma WHO Classification Update, Genomics, and Imaging: What the Radiologists Need to Know.

  2020cites this paper
• A comprehensive overview on the molecular biology of human glioma: what the clinician needs to know

  2020cites this paper
• Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis

  2020cites this paper
• Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas.

  2020cites this paper
• Emerging Pharmacological Treatments for Cerebral Edema: Evidence from Clinical Studies.

  2020cites this paper
• The Imaging Features of Isocitrate Dehydrogenase Mutant Gliomas

  2020cites this paper
• Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas

  2020cites this paper
• Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma

  2019cites this paper
• A machine learning-based prediction model of H3K27M mutations in brainstem gliomas using conventional MRI and clinical features.

  2019cites this paper
• Combined texture analysis of diffusion-weighted imaging with conventional MRI for non-invasive assessment of IDH1 mutation in anaplastic gliomas.

  2019cites this paper
• Apparent Diffusion Coefficient as a Predictive Biomarker for Survival in Patients with Treatment-Naive Glioblastoma Using Quantitative Multiparametric Magnetic Resonance Profiling.

  2019cites this paper
• Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning.

  2019cites this paper
• Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas

  2019cites this paper
• Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research

  2019cites this paper
• Analysis of the Factors Affecting the Prognosis of Glioma Patients

  2019cites this paper
• Updates in the Neuoroimaging and WHO Classification of Primary CNS Gliomas: A Review of Current Terminology, Diagnosis, and Clinical Relevance From a Radiologic Prospective

  2019cites this paper
• Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI.

  2019cites this paper
• IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region

  2019cites this paper
• Diffusion Tensor Imaging Reveals Microstructural Heterogeneity of Normal-Appearing White Matter and Related Cognitive Dysfunction in Glioma Patients

  2019cites this paper
• Tumor cell phenotype and heterogeneity differences in IDH1 mutant vs wild-type gliomas

  2019cites this paper
• 18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

  2019cites this paper
• Divide and Conquer: Stratifying Training Data by Tumor Grade Improves Deep Learning-Based Brain Tumor Segmentation

  2019cites this paper
• Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.

  2019cites this paper
• Interrelationships between molecular subtype, anatomical location, and extent of resection in diffuse glioma: a systematic review and meta-analysis

  2019cites this paper
• Comparison of Immunogenetic Properties of Glial Tumors with Advanced Magnetic Resonance Imaging Findings.

  2019cites this paper
• Radiomics and Machine Learning

  2019cites this paper
• The Path Forward: The Standardized Brain Tumor Imaging Protocol (BTIP) for Multicenter Trials

  2019cites this paper
• Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas

  2019cites this paper
• Review of WHO 2016 Changes to Classification of Gliomas; Incorporation of Molecular Markers

  2019cites this paper
• MRS for D-2HG Detection in IDH-Mutant Glioma

  2019cites this paper
• Overall Survival Prediction Using Conventional MRI Features

  2019cites this paper
• Diagnosis and management of multiple high-grade gliomas: a retrospective study

  2019cites this paper